Tag: biosimilars

Planning for Patent Expiry: What Patients and Healthcare Systems Need to Do Now

When drug patents expire, prices drop-but not always for patients. Learn how patients and healthcare systems can prepare for generic and biosimilar transitions to save money and avoid disruptions.